I
nfection of a host results in the activation, proliferation and differentiation of rare naive antigen-specific CD8 1 T cells. Appropriate initiation of the CD8
1 T-cell response occurs when the lymphocyte interacts with its cognate antigen presented by MHC class I on antigen-presenting cells within secondary lymphoid organs. During this process, the antigen-presenting cells actively shape the early CD8
1 T-cell response by their expression of costimulatory molecules and secretion of cytokines. This results in the exponential expansion of antigenspecific CD8
1 T cells. Subsequently, the majority of the antigen-specific CD8 1 T cells die during contraction, while a small proportion of the antigen-specific CD8 1 T cells survive to form the memory CD8 1 T-cell population. Numerous studies have shown that the effector CD8 1 Tcell population found at the peak of the immune response is extremely heterogeneous with each subpopulation having different memory potential.
1 Heterogeneity within the effector CD8 1 T-cell population can be resolved by a combination of IL-7Ra/CD127 and KLRG1 expression to distinguish terminal effector CD8 (Figure 1b) . 7 By the peak of the CD8 1 T-cell response, Yuzefpolskiy et al. 6 found that effector CD8 1 T cells in the lymph nodes displayed reduced in vivo degranulation, consistent with the ex vivo observation that granzyme B levels within the central memory (Tcm) MPEC population was more rapidly downregulated ( Figure 1c) . 7 Moreover, the fact that lymph node-derived effector CD8 1 T cells shut down their CTL effector program earlier than other tissues might indicate that those cells undergo fewer antigen encounters and/or an inflammatory environment more conducive with memory cell differentiation, thus explaining why effector CD8 1 T cells from lymph nodes were the best source of memory precursors irrespective of their cell surface phenotype. 9 However, in peripheral organs that are more rich in viral antigen, Yuzefpolskiy et al. 6 found that MPECs had enhanced in vivo degranulation over SLECs (Figure 1c ). This seemingly counterintuitive finding could shed some light on in vivo CD8 1 T-cell biology. First, this result suggests that SLECs may undergo continual engagement with cognate antigen which eventually leads to their functional exhaustion and death. Second, the MPECs may be recently recruited to or preferentially survive within peripheral tissues and sites of antigen occurrence to maintain an effective, sterilizing immune response. Furthermore, retention of effector function by MPECs in peripheral tissues might explain why Trm and Tem populations retain high effector function potential at memory.
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CONCLUSIONS
This exciting new in vivo degranulation assay developed by Sarkar and colleagues 6 further solidifies the notion that all CD8
1 T cells pass through a requisite cytotoxic stage, and also elucidates novel biology occurring during an in vivo CD8 1 T-cell response. Understanding how migratory, survival or retention patterns of effector CD8
1 T cells regulate in vivo effector function, generation of protective immunity and long-lived memory CD8
1 T-cell formation using this new in vivo degranulation assay and other newly developed techniques provides an exciting future for T-cell biology. Figure 1 Potential pathway for the development of effector and memory CD8 1 T-cell populations in relation to their effector function. Upon activation naive antigen-specific CD8 1 T cells rapidly downregulate the IL-7 receptor to form an EEC population. This population is the earliest effector phase that can be distinguished based on KLRG1 and IL-7R and is already associated with high levels of CTL function and potential (a). EECs may further differentiate into short-lived, terminally differentiated SLECs or long-lived memory precursors (MPECs), or remain phenotypically as an EEC. These effector phases are also associated with high levels of CTL effector function, as antigen is present and granzyme B expression can be linked to in vivo and ex vivo degranulation (b). As effector T-cell populations contract and memory populations are established, a hierarchy of CTL effector potential emerges from these populations (c, d). Trm residing in peripheral tissues express constitutively high granzyme B levels, whereas Tem and Tcm display a reduced CTL potential, at least until antigen re-exposure.
